ONNVF Stock Chart & Stats
$0.46
>-$0.01(-0.81%)
At close: 4:00 PM EDT
$0.46
>-$0.01(-0.81%)
Day’s Range― - ―
52-Week Range$0.38 - $2.65
Previous CloseN/A
Volume3.52K
Average Volume (3M)2.27K
Market Cap
$62.23M
Enterprise Value$84.08
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding59,565,857
10 Day Avg. Volume645
30 Day Avg. Volume2,266
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Onco-Innovations Ltd. News
ONNVF FAQ
What was Onco-Innovations Ltd.’s price range in the past 12 months?
Onco-Innovations Ltd. lowest stock price was $0.38 and its highest was $2.65 in the past 12 months.
What is Onco-Innovations Ltd.’s market cap?
Onco-Innovations Ltd.’s market cap is $62.23M.
When is Onco-Innovations Ltd.’s upcoming earnings report date?
Onco-Innovations Ltd.’s upcoming earnings report date is Aug 05, 2026 which is in 9 days.
How were Onco-Innovations Ltd.’s earnings last quarter?
Onco-Innovations Ltd. released its earnings results on Apr 07, 2026. The company reported -$0.038 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Onco-Innovations Ltd. overvalued?
According to Wall Street analysts Onco-Innovations Ltd.’s price is currently Overvalued.
Does Onco-Innovations Ltd. pay dividends?
Onco-Innovations Ltd. does not currently pay dividends.
What is Onco-Innovations Ltd.’s EPS estimate?
Onco-Innovations Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Onco-Innovations Ltd. have?
Onco-Innovations Ltd. has 59,565,857 shares outstanding.
What happened to Onco-Innovations Ltd.’s price movement after its last earnings report?
Onco-Innovations Ltd. reported an EPS of -$0.038 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.902%.
Which hedge fund is a major shareholder of Onco-Innovations Ltd.?
Currently, no hedge funds are holding shares in ONNVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Onco-Innovations Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-61.62%
Trailing 12-Months
Company Description
Onco-Innovations Ltd.
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.